Ratings by RBC Capital (Ryan Halsted)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/19/2026 | Cencora Inc | COR | New Coverage | Sector Perform (N/A) |
312.52 (330.95) |
5.9% | Details | |
| 8/19/2026 | McKesson | MCK | New Coverage | Sector Perform (N/A) |
859.92 (907.99) |
5.59% | Details | |
| 8/19/2026 | Cardinal Health | CAH | New Coverage | Outperform (N/A) |
235.66 (247.18) |
4.89% | Details | |
| 8/6/2026 | Medline Inc | MDLN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2026 | Charles River Labs | CRL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2026 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 7/24/2026 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2026 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2026 | Healthcare Services Group | HCSG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/13/2026 | Charles River Labs | CRL | New Coverage | Outperform (N/A) |
175.65 (288.50) |
64.25% | Details | |
| 3/3/2026 | Medpace | MEDP | New Coverage | Outperform (N/A) |
451.76 (591.29) |
30.89% | Details | |
| 3/3/2026 | Healthcare Services Group | HCSG | New Coverage | Sector Perform (N/A) |
21.77 (21.82) |
0.23% | Details | |
| 3/3/2026 | IQVIA Holdings | IQV | New Coverage | Outperform (N/A) |
178.81 (267.77) |
49.75% | Details | |
| 2/26/2026 | Medline Inc | MDLN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2026 | Evolent Health | EVH | Maintain | (N/A) |
|
Details | ||
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Outperform (N/A) |
41.25 (36.59) |
-11.3% | Details |
